Trial intelligence / Profile preview

HOPE-e: Duavive in Hand Osteoarthritis

NCT04036929Completed

Sponsor
University of Oxford
Start
May 2019
Primary completion
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in hand osteoarthritis comparing Estrogen-bazedoxifene with Placebo (2 arms). Primary endpoints: Rates of eligible participant identification and recruitment/randomisation at 1 year, Retention rates at 1 year and 3 more. Started May 2019; status: completed.

02

Drugs

bazedoxifene + conjugated estrogens
03

Conditions

hand osteoarthritis

Beyond the preview

Go deeper on NCT04036929.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04036929.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call